Search Results
Nov 13, 2025, 08:25 ET Shareholders who lost money in shares of Inspire Medical Systems, Inc. (NYSE: INSP) Should Contact Wolf Haldenstein Immediately
device. Billing and Medicare Reimbursement Issues: Although Inspire V's CPT code was approved for Medicare, billing software updates did not take effect until July 1, delaying claims and reimbursement processing.→
More news about: Wolf Haldenstein Adler Freeman & Herz LLP
Nov 13, 2025, 08:15 ET Axtria Unveils AI-Powered Launch Excellence to Accelerate Success for Emerging Pharma Companies
teams to compete effectively with larger players and make faster, smarter, and more patient-centric decisions. It is no longer about big vs small, but about fast vs slow, and we help emerging pharma gain this competitive edge." To learn more, visit:
More news about: Axtria, Inc.
Nov 13, 2025, 08:15 ET Axtria Unveils AI-Powered Launch Excellence to Accelerate Success for Emerging Pharma Companies
teams to compete effectively with larger players and make faster, smarter, and more patient-centric decisions. It is no longer about big vs small, but about fast vs slow, and we help emerging pharma gain this competitive edge." To learn more, visit:
More news about: Axtria, Inc.
Nov 13, 2025, 08:03 ET NextPlat Reports Third Quarter 2025 Results
through October and into early November and is currently anticipated to drive a significant sequential prescription volume increase in the fourth quarter vs. the third quarter of 2025 and into 2026. The Company is also currently working to optimize inventory levels in its PharmcoRx pharmacies, which are expected
More news about: NextPlat Corp.
Nov 13, 2025, 07:02 ET Deloitte Survey Shows Tech Execs Driving Growth, Shaping Strategy and Eyeing the CEO Seat
(35% vs. 29%) and attracting and retaining customers (34% vs. 30%). They are the primary leaders implementing GenAI across the organization (42% vs. 36%). They are more likely to report to the CEO (49% vs. 46%)
More news about: Deloitte LLP
Nov 13, 2025, 07:00 ET Alliance Reports Third Quarter 2025 Results
Revenue increased 14% vs. prior year with strong performance across all end markets Net Income of $32.9 million reflecting robust topline, cost optimization
More news about: Alliance Laundry Systems
Nov 13, 2025, 06:45 ET Neutrogena® and OGX® Leverage Decades of Skin Expertise with Latest Hair Innovations
https://theindustry.beauty/new-data-reveals-top-skincare-ingredients-of-2024/iii due to breakage when used with Hair Restore shampoo and conditioner vs non-conditioning shampoo.iv Vogue International LLC calculation based on Scantrack for the Hair Care Repair category for the 52 weeks
More news about: Kenvue Inc.
Nov 13, 2025, 06:00 ET Nearly Half of Warehouse Workers Receive Raises Because of Warehouse Automation
automation are more than three times as likely to stay at their job longer than leave early (36% vs 11%). Moreover, workers are nearly 3x more likely to apply to warehouses with automation than those without (37% vs 13%). Safety supercharge: three in five
More news about: Exotec
Nov 13, 2025, 03:27 ET ADNOC Gas Delivers Best-Ever Q3 Results, Demonstrating Resilience and Growth in a Dynamic Market
Q3 25 vs. Q3 24
More news about: ADNOC Gas
Nov 13, 2025, 03:18 ET ADNOC Gas Delivers Best-Ever Q3 Results, Demonstrating Resilience and Growth in a Dynamic Market
Q3 25 vs. Q3 24
More news about: ADNOC Gas
Nov 13, 2025, 02:13 ET Varvee Global Limited (VGL) Posts Strong Operational Profit & EBDITA for Q2FY26: +80% Revenue Growth, 49.8% EBITDA Margin; PAT +23.5% YoY; H1 PAT +15.7% and Attaining Near-Zero Debt
Deleveraging continues: Non-current borrowings ₹2,290.4 million and current borrowings ₹520.1 million vs FY25; finance cost down 84.38% YoY in H1 to ₹14.27 million (near-zero in Q2).
More news about: Varvee Global Limited (VGL)
Nov 12, 2025, 18:30 ET Ascletis Announces Co-formulation of ASC36, Once-Monthly Next-Generation Amylin Receptor Agonist and ASC35, Once-Monthly Next-Generation GLP-1R/GIPR Dual Agonist for Clinical Development
(p <0.0001 vs eloralintide monotherapy; p <0.0001 vs co-formulation of eloralintide and tirzepatide)
More news about: Ascletis Pharma Inc.
Nov 12, 2025, 16:05 ET CISCO REPORTS FIRST QUARTER EARNINGS
Vs. Q1 FY 2025
More news about: Cisco Systems, Inc.
Nov 12, 2025, 14:42 ET PACSUN BRINGS FIGHT NIGHT ENERGY TO NEW YORK CITY AHEAD OF VECHAIN UFC 322: DELLA MADDALENA VS. MAKHACHEV WITH A CAPSULE COLLECTION AND ATHLETE ACTIVATION
multimedia:https://www.prnewswire.com/news-releases/pacsun-brings-fight-night-energy-to-new-york-city-ahead-of-vechain-ufc-322-della-maddalena-vs-makhachev-with-a-capsule-collection-and-athlete-activation-302613536.html
More news about: Pacsun
Nov 12, 2025, 13:39 ET Somnia Anesthesia Releases 2025 Anesthesia Labor Market Study
prioritize work-life balance, team culture, and autonomy in decision-making. Hospital vs. ASC Preferences: Hospitals remain the preferred setting for many, but inflexible schedules and outdated staffing models are driving attrition.
More news about: Somnia Anesthesia
Nov 12, 2025, 11:15 ET APhA Foundation announces 2025 - 2026 Incentive Grant recipients
Real-World Comparison of sofosbuvir/velpatasvir (Epclusa) vs. glecaprevir/pibrentasvir (Mavyret) in an FQHC Population
More news about: American Pharmacists Association Foundation
Nov 12, 2025, 10:19 ET MNA Nurse Picket Outside Pats-Jets Game; Dana-Farber Foxborough Nurses Advocating November 13 for Fair Wages to Ensure Quality Patient Care
will hold an informational picket on Thursday, November 13, from 5 p.m. to 6:30 p.m. outside Patriot Place in the lead up to the 8:15 p.m. Patriots vs. Jets game at Gillette Stadium. The nurses, represented by the Massachusetts Nurses Association (MNA), are calling on DFCI management to address an "unacceptable"
More news about: Massachusetts Nurses Association
Nov 12, 2025, 09:00 ET Duality Technologies Enables Secure GenAI Workflows on NVIDIA GPUs
AI: Run secure LLMs and encrypted RAG on Confidential NVIDIA H100s Scalable Performance: Orders-of-magnitude faster runtimes vs CPU-only workloads Enterprise-Ready: Meets the needs of regulated industries, defense, healthcare, and AI-native companies
More news about: Duality Technologies
Nov 12, 2025, 09:00 ET Holiday Fraud & Scams Threatens More Than Wallets: New Iris Data Reveals Emotional Toll on Victims
Lower-income victims were twice as likely as higher-income victims to feel depressed or hopeless (22% vs. 11%). Rural victims reported frustration (79%) and anger (66%) at higher levels than urban respondents,
More news about: Iris Powered by Generali
Nov 12, 2025, 08:14 ET NORTH AMERICAN MANUFACTURERS CUT ORDERS AS GLOBAL SUPPLY CHAINS REMAIN UNDERUTILIZED IN OCTOBER: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX
NORTH AMERICA: Index fell to its lowest level since March (-0.45 in October, vs. -0.25 previously), signaling capacity at the region's suppliers went underutilized to the greatest extent since prior to April's sweeping tariff announcements.
More news about: GEP
Nov 12, 2025, 08:14 ET NORTH AMERICAN MANUFACTURERS CUT ORDERS AS GLOBAL SUPPLY CHAINS REMAIN UNDERUTILIZED IN OCTOBER: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX
NORTH AMERICA: Index fell to its lowest level since March (-0.45 in October, vs. -0.25 previously), signaling capacity at the region's suppliers went underutilized to the greatest extent since prior to April's sweeping tariff announcements.
More news about: GEP
Nov 12, 2025, 08:00 ET Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
months in the Control Arm, HR 0.84, p-value = 0.1712.Event-free rate favors Sirexatamab Arm beginning at month 9 (53 vs 47%) with further separation at month 12 (34 vs 23%). Advancing DKK1 biomarker diagnostic test and engaging with
More news about: Cypherpunk Technologies Inc.
Nov 12, 2025, 08:00 ET Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
months in the Control Arm, HR 0.84, p-value = 0.1712.Event-free rate favors Sirexatamab Arm beginning at month 9 (53 vs 47%) with further separation at month 12 (34 vs 23%). Advancing DKK1 biomarker diagnostic test and engaging with
More news about: Cypherpunk Technologies Inc.
Nov 12, 2025, 07:51 ET Samsonite Group S.A. Announces Results for the Three Months and Nine Months Ended September 30, 2025
2025 vs. 2024
More news about: Samsonite
Nov 12, 2025, 07:44 ET Neutron and FinFan Announce Strategic Partnership to Power Lightning Network Infrastructure Across Vietnam
consumer transactions. Lower operating costs: Lightning Network reduces per-transaction costs vs. legacy rails. Compliance-ready integration: Enterprise controls, auditability, and integration
More news about: Neutron